These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immune correlates of protection from HIV and AIDS - more answers but yet more questions. Heeney JL; Beverley P; McMichael A; Shearer G; Strominger J; Wahren B; Weber J; Gotch F Immunol Today; 1999 Jun; 20(6):247-51. PubMed ID: 10354547 [No Abstract] [Full Text] [Related]
6. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys. Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422 [TBL] [Abstract][Full Text] [Related]
7. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys. Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628 [TBL] [Abstract][Full Text] [Related]
8. High hopes for HIV vaccine. Ahmad K Lancet Infect Dis; 2003 Feb; 3(2):62. PubMed ID: 12560178 [No Abstract] [Full Text] [Related]
9. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques. Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630 [TBL] [Abstract][Full Text] [Related]
10. Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection. Xu R; Srivastava IK; Kuller L; Zarkikh I; Kraft Z; Fagrouch Z; Letvin NL; Heeney JL; Barnett SW; Stamatatos L Virology; 2006 Jun; 349(2):276-89. PubMed ID: 16527321 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic dendritic-cell vaccine for simian AIDS. Lu W; Wu X; Lu Y; Guo W; Andrieu JM Nat Med; 2003 Jan; 9(1):27-32. PubMed ID: 12496959 [TBL] [Abstract][Full Text] [Related]
12. HIV and SIV CTL escape: implications for vaccine design. Goulder PJ; Watkins DI Nat Rev Immunol; 2004 Aug; 4(8):630-40. PubMed ID: 15286729 [No Abstract] [Full Text] [Related]
13. Efficient priming of simian/human immunodeficiency virus (SHIV)-specific T-cell responses with DNA encoding hybrid SHIV/hepatitis B surface antigen particles. Puaux AL; Marsac D; Prost S; Singh MK; Earl P; Moss B; Le Grand R; Riviere Y; Michel ML Vaccine; 2004 Sep; 22(27-28):3535-45. PubMed ID: 15315833 [TBL] [Abstract][Full Text] [Related]
14. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3. Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317 [TBL] [Abstract][Full Text] [Related]
15. The role of the SIV model in AIDS vaccine research. Friedrich TC; Watkins DI IAVI Rep; 2005; 9(2):1, 6-8. PubMed ID: 16156073 [No Abstract] [Full Text] [Related]